Paul Badawi - Mar 16, 2023 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role
President and CEO, Director
Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Paul Badawi
Stock symbol
SGHT
Transactions as of
Mar 16, 2023
Transactions value $
$0
Form type
4
Date filed
3/21/2023, 06:15 AM
Previous filing
Jan 5, 2023
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Award $0 +177K +3.46% $0.00 5.28M Mar 16, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGHT Stock Option (Right to Buy) Award $0 +226K $0.00 226K Mar 16, 2023 Common Stock 226K $9.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock").
F2 Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i).
F3 Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.